<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Tuberculosis has taken on a new face in the context of emergent drug use. The combination of conditions such as HIV infection, hepatitis B or C, arising from the use of injectable drugs create serious problems in hospitals. In this new context, the authors analyze epidemiological aspects, predisposing factors, clinical expressions and therapeutic solutions for these cases, but also the programs that must be adopted to allow the control of this new worldwide challenge.</p>
</abstract>

Tuberculosis has taken on a new face in the context of emergent drug use. The combination of conditions such as HIV infection, hepatitis B or C, arising from the use of injectable drugs create serious problems in hospitals. In this new context, the authors analyze epidemiological aspects, predisposing factors, clinical expressions and therapeutic solutions for these cases, but also the programs that must be adopted to allow the control of this new worldwide challenge.

Pulmonary TB Faces in the New Context of Drug Users

Internal Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Pulmonary TB Faces in the New Context of Drug Users"}

Tuberculosis has taken on a new face in the context of emergent drug use. The combination of conditions such as HIV infection, hepatitis B or C, arising from...

Pulmonary TB Faces in the New Context of Drug Users

Publié en ligne: 15 avr. 2023

Pages: 57 - 71

DOI: https://doi.org/10.2478/inmed-2023-0238

Mots clés
tuberculosis, drugs, HIV, hepatitis B and C

© 2023 Florin Mihălţan et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Pulmonary TB Faces in the New Context of Drug Users

Publié en ligne: 15 avr. 2023

Pages: 57 - 71

DOI: https://doi.org/10.2478/inmed-2023-0238

Mots cléstuberculosis, drugs, HIV, hepatitis B and C

© 2023 Florin Mihălţan et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Mots clés
tuberculosis, drugs, HIV, hepatitis B and C